IIUM Repository

Ant 4,4, a polyamine-anthracene conjugate, induces cell death and recovery in human promyelogenous leukemia cells (HL-60)

Rui, Traquete and Abdul Ghani, Radiah and Phanstiel, Otto and Heather, Wallace (2013) Ant 4,4, a polyamine-anthracene conjugate, induces cell death and recovery in human promyelogenous leukemia cells (HL-60). Amino Acids, 44 (4). pp. 1193-1203. ISSN 0939-4451

[img] PDF (Paper2) - Published Version
Restricted to Registered users only until 1 December 2015.

Download (1MB) | Request a copy

Abstract

One of the major problems in cancer therapy is the lack of specificity of chemotherapeutic agents towards cancer cells, resulting in adverse side effects. One means to counter this is to selectively deliver the drug to the cancer cell. Cancer cells accumulate increased concentrations of polyamines compared to normal cells, mainly through an increased uptake of preformed polyamines via the polyamine transport system (PTS). Furthermore, the nonstringent structural requirements of the PTS enable the transport of a range of polyamine-based molecules. Thus, the PTS can be used to transport compounds linked to polyamines selectively to cancer cells. In our laboratory, polyamine–anthracene conjugates have shown potent antitumour activity towards HL-60 cells. The aim of this study was to determine the cytotoxicity of Ant-4,4, a homospermidine–anthracene conjugate, and assess the long-term effects by determining whether cancer cells were able to recover from treatment. During exposure, Ant-4,4 was an effective growth-inhibitory agent in HL-60 cells decreasing viable cell number, protein and polyamine content. Evidence indicates concomitant cell-cycle arrest and increased apoptosis. Once the drug was removed, HL-60 cells recovered gradually over time. Increasing cell number, protein content and polyamine content, as well as diminished effects on cell-cycle and apoptotic stimuli were observed over time. These data suggest that, despite being an effective way of delivering anthracene, these polyamine conjugates do not exert long-lasting effects on HL-60 cells.

Item Type: Article (Journal)
Additional Information: 4458/34725
Uncontrolled Keywords: Cancer; Polyamine conjugate; Recovery of cancer cells; Targeted drug delivery
Subjects: R Medicine > RM Therapeutics. Pharmacology > RM300 Drugs and their action
Kulliyyahs/Centres/Divisions/Institutes (Can select more than one option. Press CONTROL button): Kulliyyah of Allied Health Sciences
Depositing User: Dr Radiah Abdul Ghani
Date Deposited: 23 Jan 2014 08:24
Last Modified: 23 Jan 2014 08:24
URI: http://irep.iium.edu.my/id/eprint/34725

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year